The French journal of urology最新文献

{"title":"Retropubic autologous semitendinosus tendon transplant for female stress urinary incontinence treatment: A case report.","authors":"Anne Baumelou-Naudi, Xavier Bayle, Xavier Deffieux","doi":"10.1016/j.fjurol.2026.103137","DOIUrl":"10.1016/j.fjurol.2026.103137","url":null,"abstract":"<p><p>Worldwide, non-absorbable synthetic mid-urethral slings (MUS) are under surveillance by health authorities. It is required to re-evaluate and to develop alternatives, particularly those using the patient's own tissue (autologous techniques). We report the case of a 53-year-old patient who underwent surgical implantation of the semitendinosus tendon in the mid-urethral space via a retropubic approach, as the patient refused the implantation of conventional synthetic material. The tendon was harvested from the left knee via an anterior approach using a technique well-known by orthopedic surgeons and implanted as a retropubic MUS. The procedure, performed under general anesthesia in an outpatient procedure, was performed without peroperative complication. Postoperative bladder outlet obstruction symptoms disappeared after one week. The functional outcome and the patient reported outcome at 6 months follow-up were successful (PGI-I=1, USP=0/6/0, ICIQ-UI-SF=0).</p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103137"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148102316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prospective registry for patients undergoing artificial urinary sphincter surgery for female stress urinary incontinence due to intrinsic sphincter deficiency: Study protocol.","authors":"Marie-Hélène Vinckier, Benoît Peyronnet, Emmanuel Chartier-Kastler, Luis Lopez-Fando, Marie-Aimée Perrouin-Verbeé, Laurent Wagner, Roman Zachoval, Karl-Dietrich Sievert, Gilles Karsenty, Wim Witjes, Xavier Biardeau, Grégoire Capon, Nikesh Thiruchelvam, François Hervé, François Hervé, Paola Calleja Hermosa, Alain Ruffion, Gommert Van Goeveringe, Xavier Gamé, Aurélien Descazeaud, Frank Van der Aa","doi":"10.1016/j.fjurol.2026.103140","DOIUrl":"10.1016/j.fjurol.2026.103140","url":null,"abstract":"<p><strong>Background and objective: </strong>Stress urinary incontinence (SUI) is a common yet often undertreated condition. While several treatment options exist for moderate SUI, women with severe incontinence - particularly due to intrinsic sphincter deficiency (ISD) or a fixed urethra - often have limited effective options after failed procedures. The artificial urinary sphincter (AUS) is the gold standard for severe incontinence in men, but its use in women remains limited due to surgical complexity, higher complication rates, and restricted availability to specialized centers. Consequently, high-quality evidence supporting its use in women is lacking. The VENUS registry aims to address this gap by collecting prospective, standardized data across multiple European centers.</p><p><strong>Methods: </strong>This is a prospective, non-controlled cohort study evaluating outcomes of AUS implantation in female patients using various surgical approaches (robot-assisted, laparoscopic, open, or other). Data will be collected across European centers (NCT04114266). The primary outcome is the cure rate of AUS implantation for female SUI due to ISD. Secondary outcomes include patient-reported outcomes, urodynamic and uroflowmetric changes, postoperative complications, and revision-free survival. The study aims to recruit 150 patients with a follow-up of 5 years.</p><p><strong>Conclusion: </strong>The VENUS registry will provide real-world evidence on the safety and efficacy of AUS in women. Its findings may support broader adoption and future trials, while identifying clinical and surgical factors associated with successful outcomes, ultimately improving care for women with severe SUI.</p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103140"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148214157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Shifting risk profile in radical prostatectomy over 18 years: A bicentric French study of 8,358 patients.","authors":"Yann Neuzillet, Joao Paulo Barbosa de Oliveira, François Rozet, Eric Barret, Denis Bohin, Pierre-Olivier Bosset, Claire Deleuze, Tarek Ghoneim, Camille Lanz, Petr Macek, Maxime Pattou, Lara Rodriguez Sanchez, Yanish Soorojebally, Victor Vanalderwerelt, Thierry Lebret, Xavier Cathelineau","doi":"10.1016/j.fjurol.2026.103152","DOIUrl":"10.1016/j.fjurol.2026.103152","url":null,"abstract":"<p><strong>Introduction: </strong>Radical prostatectomy (RP) practice has been transformed by active surveillance (AS) guidelines for low-risk prostate cancer and the 2014 ISUP Gleason reclassification. The aim of this study was to describe the temporal evolution of clinical and pathological characteristics of patients undergoing RP at two high-volume French centers over 18 years.</p><p><strong>Material: </strong>We retrospectively analyzed 8,358 consecutive RPs performed between January 2007 and December 2025 at Hôpital Foch and Institut Montsouris (Paris). Patients were stratified by D'Amico risk classification across three periods (2007-2012, 2013-2018, 2019-2025).</p><p><strong>Results: </strong>Low-risk patients declined from 4.5% to 0.6% (P<0.001); high-risk patients increased from 9.5% to 21.7% (P<0.001). Biopsy Gleason score≤6 fell from 48.0% to 4.2% (P<0.001). Pathological stage≥pT3 rose from 30.5% to 47.3% (P<0.001) and lymph node involvement (pN1) from 1.0% to 5.4% (P<0.001). Median age increased from 62.6 to 66.2 years (P<0.001). These shifts accelerated after 2012-2014, coinciding with major AFU guideline revisions and the ISUP reclassification.</p><p><strong>Conclusion: </strong>This large bicentric series demonstrates a profound and sustained shift in the risk profile of patients undergoing RP over 18 years, with near-disappearance of low-risk cases and growing proportions of high-risk and pathologically advanced disease, which may reflect successful guideline-concordant AS implementation.</p><p><strong>Level of evidence: </strong>Low.</p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103152"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148341776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optimal duration of urethral catheterization in ThuLEP: A randomized prospective pilot study.","authors":"Miguel Ángel Gómez-Luque, Rubén Campanario-Pérez, Nadia María Curbelo-Ascanio, Enrique Argüelles-Salido, Cristina García-Sánchez, Rafael Antonio Medina-López","doi":"10.1016/j.fjurol.2026.103172","DOIUrl":"10.1016/j.fjurol.2026.103172","url":null,"abstract":"<p><strong>Introduction: </strong>Lower urinary tract symptoms (LUTS) from benign prostatic obstruction (BPO) are common in aging men. Surgical interventions such as TURP and laser enucleation are established treatments for drug-refractory BPO. Holmium laser enucleation (HoLEP) has demonstrated favorable long-term safety and efficacy with shorter hospitalization and catheterization times compared to standard TURP. Thulium laser enucleation (ThuLEP) emerges as an effective and safe option, potentially offering advantages including reduced blood loss and shorter catheterization periods compared to TURP. Postoperative catheterization duration following laser enucleation varies among institutions, with an increasing trend toward early catheter removal. Previous studies support the feasibility of same-day catheter removal after HoLEP in selected patients. This study aims to compare outcomes of 24-hour versus 72-hour catheterization following ThuLEP.</p><p><strong>Material and methods: </strong>This randomized prospective pilot study was designed to explore whether 24-hour catheterization yields comparable outcomes to 72-hour catheterization in terms of postoperative voiding dynamics (Qmax), with the aim of generating preliminary evidence for future confirmatory trials. Patients were randomly assigned preoperatively to catheter removal at 24h (Group 1) or 72h (Group 2). Validated questionnaires (SF-36, ICIQ-SF, IPSS) were administered preoperatively, before discharge, and at follow-up, with uroflowmetry performed. A total of 42 patients (21 per group) were included.</p><p><strong>Results: </strong>No clinically significant differences were observed between groups. Postoperative complications occurred in 7 cases: 1 in the 24-hour group and 6 in the 72-hour group, including urinary leakage, hematuria, and acute urinary retention.</p><p><strong>Conclusion: </strong>Early catheter removal at 24h following ThuLEP appears to yield comparable urinary function and patient-reported outcomes to the standard 72-hour protocol in this cohort. These preliminary findings support the feasibility of early catheter removal and provide a basis for future confirmatory trials.</p><p><strong>Level of evidence: </strong>Level 2 (or Level IIb).</p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103172"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148623628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Performance of artificial intelligence chatbots compared with young academic urologists in reconstructive urology.","authors":"Agate Escoffier, Oussama Hedhli, Felix Campos-Juanatey, Jan Adamowicz, Lukasz Bialek, Andrea Cocci, Mikołaj Frankiewicz, Guglielmo Mantica, Maciej Oszczudłowski, Elaine J Redmond, Clemens M Rosenbaum, Wesley Verla, Marjan Waterloos, Francesco Chierigo, Malte W Vetterlein, Paul Neuville, François-Xavier Madec","doi":"10.1016/j.fjurol.2026.103150","DOIUrl":"10.1016/j.fjurol.2026.103150","url":null,"abstract":"<p><strong>Introduction: </strong>Artificial intelligence (AI) is increasingly used in surgery, but its role in reconstructive urology remains insufficiently studied. The aim of this work was to evaluate the theoretical knowledge of several AI platforms and compare their performance with that of experts from the Young Academic Urologists (YAU) group of the European Association of Urology.</p><p><strong>Materials and methods: </strong>This cross-sectional comparative study included 11 YAU experts and 4 AI platforms. Thirty-one multiple-choice questions from Chapter 82 of the Campbell-Walsh-Wein Urology Review, 3rd edition (2020), were used. Total scores and thematic scores were compared.</p><p><strong>Results: </strong>The mean score of YAU experts was 14 of 31 (SD 5.28). AI platforms achieved a mean score of 15 of 31 (SD 5.53), with no significant difference between groups (P=0.802). ChatGPT-4 achieved 24 correct answers and was surpassed by only one human expert. Subgroup analyses showed no significant differences between YAU experts and AI platforms for anatomy (P=0.272), physiology (P=0.923), therapeutic management (P=0.51) and diagnosis (P=0.611).</p><p><strong>Conclusion: </strong>AI platforms, particularly ChatGPT-4, achieved high scores on MCQs in reconstructive urology, and no statistically significant difference was observed compared with YAU experts. These findings support a potential role for AI in educational settings and for answering well-defined theoretical questions, but their use alone is not suitable for clinical reasoning. Further validation on real clinical cases is required before considering clinical implementation.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103150"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148341853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"10-year evolution of the number of surgeries for female urinary incontinence in France (2015-2024).","authors":"Pierre-Luc Dequirez, Xavier Biardeau, Denis Seguier, Amélie Demeesteere, Marine Lallemant","doi":"10.1016/j.fjurol.2026.103098","DOIUrl":"10.1016/j.fjurol.2026.103098","url":null,"abstract":"<p><strong>Objective: </strong>To assess the evolution of the number and incidence of surgical treatments for stress urinary incontinence (SUI) and of mid-urethral slings (MUS) removals and sections in France between 2015 and 2024.</p><p><strong>Methods: </strong>We conducted a nationwide, population-based, repeated cross-sectional study using administrative data from the open French national discharge summary database (openCCAM) and population data from the National Institute of Statistics (INSEE). Surgical procedures for SUI performed between 2015 and 2024 were identified and categorized as: synthetic MUS, infra-urethral myoplasty or plication, indirect cervicocystopexy, autologous sling, artificial urinary sphincter (AUS), and bulking agents. Revision surgeries of slings (complete and partial removals, and section) were also extracted. Outcomes were expressed as annual counts and incidence rates.</p><p><strong>Results: </strong>Between 2015 and 2024, the annual number of SUI surgeries in France decreased by 48.7% (41,390 to 21,213 procedures). MUS-O procedures declined by 68.7% while MUS-RP procedures initially decreased but subsequently increased to 7.6% above 2015 levels. The overall volume of MUS dropped by 56.6%, and the proportion of sling-based procedures decreased from 94.5% to 82.7%. The use of bulking agents rose by 359.9%. The number of autologous slings and of indirect cervicocystopexies decreased by 37.1%, and 64.2%, respectively. MUS removals declined by 11.7%.</p><p><strong>Conclusion: </strong>The annual number of SUI surgeries in France has been halved over the past decade, primarily due to a significant reduction in MUS-O use, a modest increase in MUS-RP use, and the rapid adoption of bulking agents.</p><p><strong>Level of evidence: 4: </strong></p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103098"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147492410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC.","authors":"Priscilla Leon, Thibaut Long Depaquit, François Audenet, Yves Allory, Alexandra Masson-Lecomte, Benjamin Pradère, Thomas Seisen, Evanguelos Xylinas, Marcq Gautier, Constance Thibault, Anne Sophie Bajeot, Doriane Prost, Morgan Rouprêt, Yann Neuzillet, Maxime Vallée, Mathieu Roumiguié","doi":"10.1016/j.fjurol.2026.103156","DOIUrl":"10.1016/j.fjurol.2026.103156","url":null,"abstract":"<p><strong>Introduction: </strong>Intravesical instillations of mitomycin C, epirubicin, and BCG are considered as the standard of care for most patients with non-muscle invasive bladder cancer (NMIBC). These guidelines aim to optimize intravesical instillations in order to improve their efficacy and decrease morbidity.</p><p><strong>Material: </strong>An analysis of good practice, available regulations, and published guidelines was conducted through an online literature search in French and English using Medline® and Embase®, up to December 2025. The following keywords were used: \"BCG\"; \"Mitomycin C\"; \"Epirubicin\"; \"Bladder\"; \"Complication\"; \"Toxicity\"; \"Adverse reaction\"; \"Prevention\"; \"Treatment\".</p><p><strong>Results: </strong>Information should be given to the patient by the attending physician before the first intravesical instillation. A medical examination to detect specific contraindications is also mandatory to select appropriate therapy. Intravesical instillations should be delivered in health-care centers where urological endoscopic procedures are performed routinely. Screening for or treating asymptomatic bacteriuria prior to intravesical chemotherapy or BCG instillation is not recommended. In the presence of a clinically apparent urinary tract infection, instillations should be postponed. Intravesical instillation can only be delivered after a bladder catheter has been inserted without any injury to the lower urinary tract. The pharmaceutical agent should be retained in the bladder for 2h. Finally, voiding within 6h after intravesical instillation should be done in the seated position and the patient should drink at least 2L of water per day for 2 days.</p><p><strong>Conclusion: </strong>The delivery of intravesical instillations of mitomycin C, epirubicin and BCG should follow a standardized procedure for better efficacy and lower morbidity.</p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103156"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148341838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"No-scalpel vasectomy: What is the learning curve?","authors":"Quentin Ducrot, Boris Delaunay, Ahmed Mansouri, François Isus, Michel Soulié, Éric Huyghe","doi":"10.1016/j.fjurol.2026.103155","DOIUrl":"10.1016/j.fjurol.2026.103155","url":null,"abstract":"<p><strong>Introduction: </strong>No-scalpel vasectomy (NSV) is a minimally invasive technique that is still not widely used in France, despite being recommended by the WHO and professional societies. The objective of this study was to examine its learning curve.</p><p><strong>Methods: </strong>We prospectively analyzed the surgical and postoperative data of a cohort of 398 consecutive patients who underwent surgery under local anesthesia during the transition of our practice from traditional vasectomy to NSSV (the last 199 patients operated on using the traditional technique, and the first 199 patients operated on using NSSV). The procedures were performed by two andrologists at a university center. Operating time was analyzed for the last 50 traditional vasectomies compared with the first 50 VSBs to establish a learning curve using the CUSUM method. Patient satisfaction with the procedure was assessed using a 1-to-5 Likert scale.</p><p><strong>Results: </strong>The mean age in our series was 39.7±6.9 years. A total of 84.8% of patients were in a relationship. The primary motivation was shifting the burden of contraception in 57% of cases. Sixty-five patients (16%) were childless. Operating time was shorter in the VSB group (14.6 vs. 21.5min) and decreased to an average of 9.4min for VSB after the 38th procedure. The peak of the learning curve occurred between the 10th and 21st procedures, depending on the surgeon. Patient satisfaction was higher for VSB (P-value=0.002). There was a non-significant trend favoring VSB regarding the rate of surgical complications (2 vs. 4 Clavien 3 complications). Efficacy was similar (98.4%).</p><p><strong>Conclusion: </strong>VSB reduces operative time compared to the traditional technique. It is quick to learn, and both patient tolerance and efficacy remain good even while surgeons are still learning the technique. It helps meet the growing demand for vasectomies and optimize operating room utilization. Optimization of the technique continues beyond the 40th procedure, but this number is quickly reached due to the short operative time and current high demand.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103155"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148335443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis of interstitial cystitis/bladder pain syndrome: Guidelines from the Committee of Female Urology (CUROPF) of the French Association of Urology (AFU).","authors":"François Meyer, Caroline Brandon, Christian Saussine, Shahed Borojeni, Pierre-Olivier Bosset, Sandrine Campagne-Loiseau, Jean-Nicolas Cornu, Laurence Donon, Lucie Even, Marie Florin, François Hervé, Sophie Hurel, Julia Klap, Marie-Aimée Perrouin-Verbe, Caroline Plassais, Claire Richard, Adrien Vidart, Souhil Lebdai, Amélie Levesque, Caroline Thuillier, Benoît Peyronnet","doi":"10.1016/j.fjurol.2026.103166","DOIUrl":"10.1016/j.fjurol.2026.103166","url":null,"abstract":"<p><p>Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition whose diagnosis relies primarily on a structured process of exclusion. Defined as chronic pelvic pain, pressure, or discomfort perceived in relation to the bladder, accompanied by at least one urinary symptom, IC/BPS encompasses significant clinical and pathophysiological heterogeneity. A thorough medical history, targeted physical examination, and validated questionnaires such as the O'Leary-Sant score (ICSI/ICPI) form the foundation of initial evaluation. Patient phenotyping - distinguishing in particular the bladder-centric from the sensitization phenotype - is essential to guide both diagnostic and therapeutic strategies. Complementary investigations include a voiding diary, urine culture, imaging (ultrasound as first-line, CT scan and MRI as second-line modalities), and cystoscopy (preferably with hydrodistension under general anesthesia), which allows identification of Hunner's lesions, measurement of anatomical bladder capacity, and targeted biopsies. Urodynamic testing is reserved for cases of diagnostic uncertainty or associated voiding dysfunction. These recommendations aim to standardize the diagnostic approach in order to optimize individualized management in patients suffering from IC/BPS.</p>","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":" ","pages":"103166"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148498672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to \"Diagnosis of interstitial cystitis/bladder pain syndrome: Guidelines from the Committee of Female Urology (CUROPF) of the French Association of Urology (AFU)\" [The French Journal of Urology 36 (2026) 103166].","authors":"François Meyer, Caroline Brandon, Christian Saussine, Shahed Borojeni, Pierre-Olivier Bosset, Sandrine Campagne-Loiseau, Jean-Nicolas Cornu, Laurence Donon, Lucie Even, Marie Florin, Francois Hervé, Sophie Hurel, Julia Klap, Marie-Aimée Perrouin-Verbe, Caroline Plassais, Claire Richard, Adrien Vidart, Souhil Lebdai, Amélie Levesque, Caroline Thuillier, Benoît Peyronnet","doi":"10.1016/j.fjurol.2026.103176","DOIUrl":"10.1016/j.fjurol.2026.103176","url":null,"abstract":"","PeriodicalId":516865,"journal":{"name":"The French journal of urology","volume":"36 9","pages":"103176"},"PeriodicalIF":1.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148804215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}